0001181431-11-061724.txt : 20111222 0001181431-11-061724.hdr.sgml : 20111222 20111222154616 ACCESSION NUMBER: 0001181431-11-061724 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20111220 FILED AS OF DATE: 20111222 DATE AS OF CHANGE: 20111222 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Quinn Anthony CENTRAL INDEX KEY: 0001532219 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23155 FILM NUMBER: 111277425 MAIL ADDRESS: STREET 1: 128 SPRING STREET, SUITE 520 CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SYNAGEVA BIOPHARMA CORP CENTRAL INDEX KEY: 0000911326 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 561808663 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 128 SPRING STREET STREET 2: SUITE 520 CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: (781) 357-9900 MAIL ADDRESS: STREET 1: 128 SPRING STREET STREET 2: SUITE 520 CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: TRIMERIS INC DATE OF NAME CHANGE: 19970516 4 1 rrd328641.xml QUINN 122011 FORM 4 X0304 4 2011-12-20 0 0000911326 SYNAGEVA BIOPHARMA CORP GEVA 0001532219 Quinn Anthony C/O SYNAGEVA BIOPHARMA CORP. 128 SPRING ST STE 520 LEXINGTON MA 02421 0 1 0 0 SVP, Chief Medical Officer Common Stock 46035 D Stock Option (Right to Buy) 23.00 2011-12-20 4 A 0 50000 0.00 D 2021-12-19 Common Stock 50000 50000 D The Option is subject to the issuer's shareholders approving an amendment to the 2005 Stock Option plan. 25% of the total number of Shares subject to the Option vest and become exercisable on 12/20/2012 and 1/36 of the remainder of the Shares subject to the Option shall vest and become exercisable monthly thereafter. /s/ Marc A. Rubenstein, Attorney-in-Fact 2011-12-22